Public Health Europe - European Commission - EU

The European Commission organises webinars on "EU4Health Programme 2021-2027: a vision for a healthier European Union" (22 January 2021, 10:00-12:00 CET) and on “Building a European Health Union for stronger EU preparedness and response for health crises” (29 January 2021, 10:15-11.45 CET).

Director for Crisis preparedness in food, animals and plants, in charge of the Brexit files for DG SANTE, Bernard Van Goethem lays out the preparatory work carried out by DG SANTE ahead of 1 January 2021.

The European Commission has granted a conditional marketing authorisation (CMA) for the COVID‑19 vaccine developed by Moderna, the second COVID-19 vaccine authorised in the EU.

The COVID 19 vaccine developed by BioNTech and Pfizer is the first COVID-19 vaccine authorised in the EU. Doses of the approved vaccine will be available for all EU countries, at the same time, on the same conditions.